This trial will test how safe and effective a new breast cancer screening device is, and if it is useful for diagnosis.
2 Primary · 2 Secondary · Reporting Duration: 4 years
5400 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Age 35 - 100 · Female Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: